
Sign up to save your podcasts
Or


You’ve chosen the questionnaires for your trial. How hard can getting permission to use them really be?
Jasmine Walker, a linguistic validation and licensing expert, joins Farrell Healion and Edwin Cohen to unpack the world of COA licensing. From tracking down copyright holders to understanding costs, translations and digital implementation requirements, we explore why this seemingly small task can become a much bigger part of study setup.
We cover:
A practical conversation for anyone planning or delivering studies using patient, clinician or performance outcome assessments.
Another feasibility questionnaire lands in a site’s inbox. The same questions, another blank form, and often no feedback on what happened next.
Is this really how we want to start a clinical trial partnership?
In this episode of Digital Health Off the Record, Farrell Healion and Edwin Cohen discuss why site feasibility needs a rethink. From repetitive questionnaires and unrealistic recruitment expectations to missing protocol details and months of silence, we explore what the process asks of sites and whether it gives sponsors the insight they actually need.
We also discuss why past recruitment numbers need context, how relying on familiar sites can overlook new opportunities, and what better communication could change.
Farrell shares how he is approaching these challenges through OptiSite, with reusable site information, protocol synopsis feedback and clearer visibility across sponsors, CROs and sites.
In this episode:
Less time repeating answers. More time for patients.
Learn more about OptiSite: optitrial.ai/optisite
Subscribe to Digital Health Off the Record for candid conversations about clinical trials, digital health and the people making them work.
“Did you already ask a site?” And, just as importantly, “But did you also listen?”
Physician and principal investigator Viviane joins Farrell and Edwin to share the reality of running clinical trials after almost 30 years in research.
From repeated feasibility questions and delayed payments to an eConsent workflow that left a patient stuck between two systems, she explains where trial processes create extra work for sites and patients.
We explore investigator retention, fit-for-purpose training, the risks of assessing sites without context, and why meaningful oversight takes more than another signature.
What does it actually take to get clinical trial technology, connected sensors, devices and study supplies into the hands of sites and patients?
In this episode of Digital Health Off the Record, Farrell Healion and Edwin Cohen are joined by David Loughborough, Founder of LogiDCT, for a practical look behind the scenes at clinical trial logistics.
From supply chain visibility and customs challenges to wearables, sustainability and the future of DCT delivery, we explore the operational infrastructure that has to work before any clinical technology can deliver value.
Topics discussed:
04:04 - How DCT logistics have evolved
10:00 - The biggest challenges in clinical trial logistics
13:00 - Why supply chain visibility matters
17:47 - Customs and global clinical trial distribution
23:09 - Complex protocols and logistics planning
26:39 - The future of DCT logistics and "trial in a box"
29:31 - Wearables and patient engagement
31:49 - BYOD, sustainability and reducing unnecessary shipments
35:31 - Future technology and AI-enabled logistics
39:18 - Why logistics is the invisible layer behind clinical trials
If you work across clinical operations, DCTs, digital health, connected devices or clinical technology, this episode gives a look at the operational work that happens behind the technology everyone sees.
What does it really take to build a startup in the clinical-trial space?
In this episode of Digital Health Off the Record, Farrell Healion and Edwin are joined by Ashton, Founder and CEO of SheppAI, for an honest conversation about building in a complex, risk-averse industry.
Ashton shares lessons from his journey: finding genuine customer pain, testing ideas, earning trust, working with design partners, and staying focused when things do not go to plan. The conversation also explores why even well-funded partnerships can fail, and the importance of relationships, resilience, and solving problems rooted in lived experience.
Featuring Ashton, Founder and CEO of SheppAI.
Hosted by Farrell Healion and Edwin.
#ClinicalTrials #DigitalHealth #HealthTech #ClinicalResearch #Startups
In this episode
01:29 | The challenge of breaking into clinical trials
04:40 | Finding product-market fit: seek invalidation, not validation
07:09 | Building credibility and trust with prospective customers
09:15 | The problem SheppAI is solving for sponsors and vendors
15:15 | Testing a new product idea with end users
16:13 | Using prototypes to shape a focused pilot
19:05 | Why real-world feedback matters
21:04 | Building design partnerships through your network
24:24 | Why startup failures offer the biggest lessons
25:18 | When even major partnerships fail
30:29 | Staying aligned on a shared vision
33:24 | Closing advice for aspiring founders
Clinical trials increasingly depend on a complex network of technology and service providers. But with so many options, how can sponsors identify the right vendor rather than simply the best sales pitch?
In this episode, Farrell Healion and Edwin Cohen explore the clinical trial vendor selection process from both the sponsor and vendor perspectives. We discuss how to define the need, navigate the RFI and RFP stages, evaluate suppliers objectively and test whether a solution can genuinely deliver.
We cover:
Whether you are selecting a specialist provider for one study or building a long-term preferred vendor partnership, this episode offers practical advice for making a better-informed decision.
Patient recruitment remains one of the biggest causes of clinical trial delays. So why, after decades of investment, innovation and expertise, does the industry still struggle to solve it?
In this episode of Digital Health: Off the Record, Edwin Cohen and Farrell Healion are joined by patient recruitment specialist and author Ross Jackson.
Ross challenges the idea that recruitment is primarily an advertising problem. The conversation explores why recruitment and retention must be considered from the earliest stages of trial design, the critical role sites continue to play, and why opening more sites is rarely a complete solution.
The discussion also looks at recruitment costs and commercial models, the growing use of AI, and how digital twins and synthetic control arms could transform the number and type of patients required for future trials.
What we cover:
Ross leaves us with a simple but powerful principle: design every trial as though it were for you or someone you love.
Clinical trials cannot run without research sites and participants. Yet both can end up carrying significant costs while waiting to be reimbursed.
In this episode of Digital Health Off the Record, Edwin and Farrell explore the often-overlooked realities of payments in clinical trials. From site budgets that fail to capture the true workload to patient expenses that can become barriers to participation, they discuss why getting payments right is essential for sustainable and accessible research.
Building on previous conversations about site burden, patient-centred trial design and fragmented technology, they also consider whether digital payment tools are genuinely simplifying the process or creating another system for sites to manage.
In this episode, we cover:
Patient centricity is not a new topic in clinical trials, but it is one the industry still needs to keep coming back to.
In this episode of Digital Health Off the Record, Farrell Healion and Edwin Cohen explore why incorporating patient voice earlier in study design can make a real difference to recruitment, retention and the overall patient experience.
We discuss how patient input can help reduce unnecessary burden, improve protocol design, support more meaningful inclusion criteria and make trials work better around real life. We also look at where digital health technologies, DCT capabilities, patient feedback tools and patient engagement roles can help - and where simply adding more technology risks creating the opposite effect.
As always, this is an honest conversation about what the industry is getting right, where we still fall short and how we can design better trials for patients, sites and sponsors.
In this episode, we cover:
eConsent has been discussed in clinical trials for years, but it still feels underused compared with other patient-facing technologies like eCOA.
In this episode of Digital Health Off the Record, Farrell and Edwin take a practical look at what eConsent really means, why it should be more than a PDF with an electronic signature, and how it can improve the consent experience for patients, sites and sponsors.
We discuss:
As with our previous discussions on eCOA and DCT-enabling technologies, the real opportunity is not simply to digitise an existing paper process. It is to rethink how clinical trial technology can make studies clearer, more accessible and easier to manage for everyone involved.
From the publisher's feed